, NSG 318 Exam 3 – NGN Questions and
Case Scenarios (Guarantee Pass)
Table of Contents
NSG 318 EXAM 3
NSG 318 EXAM 3 STUDY GUIDE
NSG 318 EXAM 3
1. A patient is prescribed albuterol for acute bronchospasm. Which statement by
the patient indicates understanding of this medication?
• A. "I should rinse my mouth after using the inhaler."
• B. "I can use this inhaler as often as I need to."
• C. "I should store my inhaler in the refrigerator."
• D. "This medication is for long-term control of my asthma."
Answer: A
Rationale: Albuterol is a short-acting beta-2 agonist (SABA) used as a rescue inhaler.
Rinsing the mouth after use helps prevent dry mouth and oral irritation. It is not for daily
maintenance therapy and should be used as directed, not "as often as needed" without
provider guidance .
2. What is the mechanism of action of albuterol?
• A. Blocks muscarinic receptors → bronchodilation
• B. Stimulates beta-2 receptors → bronchodilation
• C. Inhibits leukotriene synthesis
• D. Stabilizes mast cells
,Answer: B
Rationale: Albuterol selectively stimulates beta-2 adrenergic receptors in bronchial
smooth muscle, inducing relaxation and dilation, which reverses bronchoconstriction.
Onset of action is 5-15 minutes .
3. A patient receiving albuterol nebulizer treatments reports tremors and
palpitations. What is the nurse's best action?
• A. Stop the treatment immediately
• B. Reassure the patient that these are expected side effects
• C. Notify the provider and hold future doses
• D. Slow the rate of administration
Answer: B
Rationale: Tremors, palpitations, tachycardia, and nervousness are common side effects
of albuterol due to peripheral nervous system stimulation and non-selective beta
stimulation. These effects are expected and not typically harmful, though the provider
should be informed if they are severe .
4. Which medication is the first-line choice for acute bronchospasm in asthma?
• A. Salmeterol
• B. Albuterol
• C. Montelukast
• D. Fluticasone
Answer: B
Rationale: Albuterol is a short-acting beta-2 agonist (SABA) with rapid onset (5-15
minutes), making it the first-line agent for acute bronchospasm. Salmeterol is a long-
acting beta-agonist (LABA) for maintenance, not rescue .
, 5. The nurse is teaching a patient about albuterol inhaler use. Which statement by
the patient indicates a need for further teaching?
• A. "I will wait 1 minute between puffs."
• B. "I should shake the inhaler well before each use."
• C. "I can stop using this when I feel better."
• D. "I should use a spacer to improve medication delivery."
Answer: C
Rationale: Albuterol should be used as prescribed, even when symptoms improve, to
prevent recurrence of bronchospasm. Patients should not stop using rescue medication
without provider guidance .
6. What should be monitored when a patient is using albuterol?
• A. Blood glucose
• B. Heart rate and respiratory status
• C. Liver function tests
• D. Serum potassium
Answer: B
Rationale: Due to potential for tachyarrhythmias and cardiac stimulation, as well as the
need to evaluate respiratory improvement, ongoing assessment of heart rate and
respiratory status is critical for safe administration .
Anticholinergic Agents
7. What is the class of tiotropium (Spiriva)?
• A. Beta-2 adrenergic agonist
• B. Anticholinergic
• C. Leukotriene receptor antagonist
Case Scenarios (Guarantee Pass)
Table of Contents
NSG 318 EXAM 3
NSG 318 EXAM 3 STUDY GUIDE
NSG 318 EXAM 3
1. A patient is prescribed albuterol for acute bronchospasm. Which statement by
the patient indicates understanding of this medication?
• A. "I should rinse my mouth after using the inhaler."
• B. "I can use this inhaler as often as I need to."
• C. "I should store my inhaler in the refrigerator."
• D. "This medication is for long-term control of my asthma."
Answer: A
Rationale: Albuterol is a short-acting beta-2 agonist (SABA) used as a rescue inhaler.
Rinsing the mouth after use helps prevent dry mouth and oral irritation. It is not for daily
maintenance therapy and should be used as directed, not "as often as needed" without
provider guidance .
2. What is the mechanism of action of albuterol?
• A. Blocks muscarinic receptors → bronchodilation
• B. Stimulates beta-2 receptors → bronchodilation
• C. Inhibits leukotriene synthesis
• D. Stabilizes mast cells
,Answer: B
Rationale: Albuterol selectively stimulates beta-2 adrenergic receptors in bronchial
smooth muscle, inducing relaxation and dilation, which reverses bronchoconstriction.
Onset of action is 5-15 minutes .
3. A patient receiving albuterol nebulizer treatments reports tremors and
palpitations. What is the nurse's best action?
• A. Stop the treatment immediately
• B. Reassure the patient that these are expected side effects
• C. Notify the provider and hold future doses
• D. Slow the rate of administration
Answer: B
Rationale: Tremors, palpitations, tachycardia, and nervousness are common side effects
of albuterol due to peripheral nervous system stimulation and non-selective beta
stimulation. These effects are expected and not typically harmful, though the provider
should be informed if they are severe .
4. Which medication is the first-line choice for acute bronchospasm in asthma?
• A. Salmeterol
• B. Albuterol
• C. Montelukast
• D. Fluticasone
Answer: B
Rationale: Albuterol is a short-acting beta-2 agonist (SABA) with rapid onset (5-15
minutes), making it the first-line agent for acute bronchospasm. Salmeterol is a long-
acting beta-agonist (LABA) for maintenance, not rescue .
, 5. The nurse is teaching a patient about albuterol inhaler use. Which statement by
the patient indicates a need for further teaching?
• A. "I will wait 1 minute between puffs."
• B. "I should shake the inhaler well before each use."
• C. "I can stop using this when I feel better."
• D. "I should use a spacer to improve medication delivery."
Answer: C
Rationale: Albuterol should be used as prescribed, even when symptoms improve, to
prevent recurrence of bronchospasm. Patients should not stop using rescue medication
without provider guidance .
6. What should be monitored when a patient is using albuterol?
• A. Blood glucose
• B. Heart rate and respiratory status
• C. Liver function tests
• D. Serum potassium
Answer: B
Rationale: Due to potential for tachyarrhythmias and cardiac stimulation, as well as the
need to evaluate respiratory improvement, ongoing assessment of heart rate and
respiratory status is critical for safe administration .
Anticholinergic Agents
7. What is the class of tiotropium (Spiriva)?
• A. Beta-2 adrenergic agonist
• B. Anticholinergic
• C. Leukotriene receptor antagonist
